KioMedine(vs)one is a unique soft implant for OsteoArthritis pain relief and outstanding response rate
KioMedine(vs)one is the new generation single-shot injection intended for the symptomatic treatment of knee osteoarthritis based on world-first exclusive animal-free KiOmedine® CM Chitosan.
- Treatment response up to 76%
- 86% of patient satisfied
- 90% of physicians satisfied
KiOmedine® CM Chitosan is a patented technology made in Belgium, resulting from years of research and innovation. Thanks to a unique structure that differs from
hyaluronic acid and natural chitosan,
KioMedine(vs)one has an exclusive
dual mechanism of action : improves lubrication and protect the endogenous synovial components thanks to its unprecedented free radical scavenging capacity.
BE